Physician profile
Michael A Jacobs
NPI 1225094352
$249,029.95
in general payments reported to CMS, 2019-2025
13 companies · $66K in 2025
The $66K reported for 2025 was more than what 96% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30K · 2020: $29K · 2021: $24K · 2022: $41K · 2023: $60K · 2024: $136 · 2025: $66K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $121K · Consulting Fee: $3,600 · Travel and Lodging: $688 · Food and Beverage: $364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $120,933.13 |
| Consulting Fee | $3,600.00 |
| Travel and Lodging | $687.96 |
| Food and Beverage | $363.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, Lp | $246,763.64 | 2019-2025 | Djo Surgical |
| Medical Device Business Services, INC. | $1,046.50 | 2022-2023 | |
| Abbott Laboratories | $468.74 | 2020-2025 | Proclaim |
| Zimmer Biomet Holdings, INC. | $248.90 | 2022-2024 | Persona |
| Stryker Corporation | $197.16 | 2019-2023 | Iconix |
| Medtronic, INC. | $107.92 | 2023-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Baxter Healthcare | $46.67 | 2019 | |
| Ferring Pharmaceuticals INC. | $33.54 | 2021 | |
| Novo Nordisk INC | $32.48 | 2019-2020 | |
| Depuy Synthes Sales INC. | $31.96 | 2022-2024 | Orthovisc |
| Amgen INC. | $26.48 | 2025 | Krystexxa |
| Arbor Pharmaceuticals, INC. | $13.71 | 2019 | |
| Pacira Therapeutics, INC. | $12.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Jacobs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.